Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related AKBA
Brean Sees Huge Upside In Akebia Shares
Akebia's Market Potential Undervalued By The Street, Says JMP
Related AI
UPDATE: Imation Chair Sends Letter to Arlington Holders: Urges Vote on GOLD Proxy Card
Top 4 Small-Cap Stocks In The Mortgage Investment Industry With The Highest EPS Growth Forecast For Next 5 Years
Annaly Capital's BV, Valuation And Dividend Compared To 17 mREIT Peers (Post Q2 2016 Earnings) - Part 1 (Seeking Alpha)

Analysts at Nomura initiated coverage on shares of Akebia Therapeutics (NASDAQ: AKBA) with a “buy” rating. The target price for Akebia Therapeutics is set to $39. Akebia Therapeutics' shares closed at $16.86 on Friday.

Credit Suisse initiated coverage on shares of Arlington Asset Investment (NYSE: AI) with a “neutral” rating. The target price for Arlington Asset Investment is set to $26. Arlington Asset Investment's shares closed at $25.65 on Friday.

SunTrust Robinson Humphrey initiated coverage on shares of Pandora Media (NYSE: P) with a “buy” rating. The target price for Pandora Media is set to $34. Pandora's shares closed at $25.31 on Friday.

Analysts at Stifel Nicolaus initiated coverage on shares of Q2 Holdings (NYSE: QTWO) with a “buy” rating. The target price for Q2 Holdings is set to $18. Q2 Holdings' shares closed at $13.68 on Friday.

Latest Ratings for AKBA

DateFirmActionFromTo
Mar 2016H.C. WainwrightMaintainsBuy
Mar 2016JMP SecuritiesMaintainsMarket Outperform
Jan 2016Credit SuisseInitiates Coverage onNeutral

View More Analyst Ratings for AKBA
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AI + AKBA)

View Comments and Join the Discussion!